TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition

The mortality rate of pancreatic adenocarcinoma is high, and the effect of traditional treatment is unsatisfactory, thus novel biomarkers are required. Although the important role of tetratricopeptide repeat domain 22 (TTC22) in colon cancer is well established, its precise role in pancreatic cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yuntao, Wang, Huizhi, Cao, Wenyu, Cao, Tianyu, Jiang, Han, Yu, Zhengyue, Zhou, Yujing, Xu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688474/
https://www.ncbi.nlm.nih.gov/pubmed/38034483
http://dx.doi.org/10.3892/ol.2023.14143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688474/
https://www.ncbi.nlm.nih.gov/pubmed/38034483
http://dx.doi.org/10.3892/ol.2023.14143

Ejemplares similares